Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Simona Songia"'
Autor:
Marco Ruella, Valentina Bertaina, Franco Locatelli, Antonio Camera, Biagio De Angelis, Francesca Del Bufalo, Concetta Quintarelli, Pietro Merli, Marika Guercio, Simona Manni, Iolanda Boffa, Matilde Sinibaldi, Stefano Di Cecca, Simona Caruso, Zeinab Abbaszadeh, Biancamaria Cembrola, Roselia Ciccone, Alberto Orfao, Lourdes Martin-Martin, Sara Gutierrez-Herrero, Maria Herrero-Garcia, Gianni Cazzaniga, Vittorio Nunes, Simona Songia, Paolo Marcatili, Frederikke I Marin, Luciana Vinti, Mattia Algeri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Externí odkaz:
https://doaj.org/article/aeeb5bd2086e49fe88021ed8c083b35c
Autor:
Marco Ruella, Valentina Bertaina, Franco Locatelli, Antonio Camera, Biagio De Angelis, Francesca Del Bufalo, Concetta Quintarelli, Pietro Merli, Marika Guercio, Simona Manni, Iolanda Boffa, Matilde Sinibaldi, Stefano Di Cecca, Simona Caruso, Zeinab Abbaszadeh, Biancamaria Cembrola, Roselia Ciccone, Alberto Orfao, Lourdes Martin-Martin, Sara Gutierrez-Herrero, Maria Herrero-Garcia, Gianni Cazzaniga, Vittorio Nunes, Simona Songia, Paolo Marcatili, Frederikke I Marin, Luciana Vinti, Mattia Algeri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Methods We evaluated the impact of a high percentage of leukemia blast contamination in patient-derived starting material (SM) on CAR T-cell drug product (DP) manufacturing. In vitro as well as in vivo models were employed to identify char
Externí odkaz:
https://doaj.org/article/fc993e58dfde4d03ab19898c5289c470
Autor:
Andrea Grioni, Grazia Fazio, Silvia Rigamonti, Vojtech Bystry, Giulia Daniele, Zuzana Dostalova, Manuel Quadri, Claudia Saitta, Daniela Silvestri, Simona Songia, Clelia T. Storlazzi, Andrea Biondi, Nikos Darzentas, Giovanni Cazzaniga
Publikováno v:
HemaSphere, Vol 3, Iss 3 (2019)
Abstract. Acute lymphoblastic leukemia (ALL) is the most frequent pediatric cancer. Fusion genes are hallmarks of ALL, and they are used as biomarkers for risk stratification as well as targets for precision medicine. Hence, clinical diagnostics purs
Externí odkaz:
https://doaj.org/article/169ff7af2f67447fae29c9a888b4b928
Autor:
Pietro Merli, Gianni Cazzaniga, Franco Locatelli, Vittorio Nunes, Zeinab Abbaszadeh, Alberto Orfao, Matilde Sinibaldi, Mattia Algeri, Frederikke Isa Marin, Maria Herrero-Garcia, Stefano Di Cecca, Paolo Marcatili, Biagio De Angelis, Concetta Quintarelli, Sara Gutiérrez-Herrero, Luciana Vinti, Lourdes Martín-Martín, Roselia Ciccone, Biancamaria Cembrola, Simona Songia, Simona Caruso, Iolanda Boffa, Simona Manni, Valentina Bertaina, Marika Guercio, Antonio Camera, Francesca Del Bufalo, Marco Ruella
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer
Quintarelli, C, Guercio, M, Manni, S, Boffa, I, Sinibaldi, M, DI Cecca, S, Caruso, S, Abbaszadeh, Z, Camera, A, Cembrola, B, Ciccone, R, Orfao, A, Martin-Martin, L, Gutierrez-Herrero, S, Herrero-Garcia, M, Cazzaniga, G, Nunes, V, Songia, S, Marcatili, P, Marin, F I, Ruella, M, Bertaina, V, Vinti, L, Del Bufalo, F, Algeri, M, Merli, P, De Angelis, B & Locatelli, F 2021, ' Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts ', Journal for ImmunoTherapy of Cancer, vol. 9, no. 6, 001514 . https://doi.org/10.1136/jitc-2020-001514
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal for Immunotherapy of Cancer
Quintarelli, C, Guercio, M, Manni, S, Boffa, I, Sinibaldi, M, DI Cecca, S, Caruso, S, Abbaszadeh, Z, Camera, A, Cembrola, B, Ciccone, R, Orfao, A, Martin-Martin, L, Gutierrez-Herrero, S, Herrero-Garcia, M, Cazzaniga, G, Nunes, V, Songia, S, Marcatili, P, Marin, F I, Ruella, M, Bertaina, V, Vinti, L, Del Bufalo, F, Algeri, M, Merli, P, De Angelis, B & Locatelli, F 2021, ' Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts ', Journal for ImmunoTherapy of Cancer, vol. 9, no. 6, 001514 . https://doi.org/10.1136/jitc-2020-001514
Digital.CSIC. Repositorio Institucional del CSIC
instname
[Abstract]: Chimeric antigen receptor T-cells (CAR T-cells) for the treatment of relapsing/refractory B-cell precursor acute lymphoblastic leukemia have led to exciting clinical results. However, CAR T-cell approaches revealed a potential risk of CD1
Autor:
Jan Trka, Bastiaan Tops, Grazia Fazio, Vincent H.J. van der Velden, Blanca Scheijen, Karol Pál, Monika Brüggemann, Giovanni Cazzaniga, Nikos Darzentas, Sonja Hänzelmann, Anton W. Langerak, Simona Songia
Publikováno v:
Leukemia, 35(3), 924-928. Nature Publishing Group
Leukemia, 35, 924-928
Leukemia
Leukemia, 35, 3, pp. 924-928
Leukemia, 35, 924-928
Leukemia
Leukemia, 35, 3, pp. 924-928
Contains fulltext : 232927.pdf (Publisher’s version ) (Open Access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e0cb16412da60f277d5a8badca7541
https://pure.eur.nl/en/publications/318d4e7b-990e-43b5-ad7d-f3b38913d135
https://pure.eur.nl/en/publications/318d4e7b-990e-43b5-ad7d-f3b38913d135
Publikováno v:
Leukemia Stem Cells ISBN: 9781071608098
Although new techniques (i.e., droplet digital-PCR, next-generation sequencing, advanced flow cytometry) are being developed, DNA-based allele-specific real-time quantitative (RQ)-PCR is still the gold standard for sensitive and accurate immunoglobul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab22a6ab89b1ce89d6962c3029eaba9
https://doi.org/10.1007/978-1-0716-0810-4_6
https://doi.org/10.1007/978-1-0716-0810-4_6
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2185
Although new techniques (i.e., droplet digital-PCR, next-generation sequencing, advanced flow cytometry) are being developed, DNA-based allele-specific real-time quantitative (RQ)-PCR is still the gold standard for sensitive and accurate immunoglobul
Potential Role of STAG1 Mutations in Genetic Predisposition to Childhood Hemato-Oncological Diseases
Autor:
Stefano Rebellato, Grazia Fazio, Claudia Saitta, Giovanni Cazzaniga, Eugenio Erba, Laura Rachele Bettini, Simona Songia, Andrea Biondi, Nicolò Panini, Giovanni Giudici, Valentina Massa
Publikováno v:
Blood. 138:1155-1155
Background. Genetic predisposition has been recently assessed in about 5-10% of pediatric tumors, including leukemias. Among genetic syndromes associated with an increased risk of developing leukemia, a possible link has been proposed for Cohesinopat
Autor:
Jos Rijntjes, K. Stamatopoulos, C. Pott, Ramón García-Sanz, Karla Plevová, Giovanni Cazzaniga, Elizabeth Macintyre, Nikos Darzentas, Blanca Scheijen, John Moppett, F. Appelt, Jack Bartram, Eva Froňková, Michael Svatoň, Frederic Davi, Michaela Kotrova, Jan Trka, Simona Songia, Kamila Stránská, Andrea Grioni, Henrik Knecht, Monika Brüggemann, David Gonzalez, Dietrich Herrmann, Michael Hummel, Karol Pál, Anthonie Willem Langerak, Tomáš Reigl, Adam Krejci, van Dongen Jjm, Groenen Pjta, J. Hancock, Peter Stewart, Bystry
Publikováno v:
Leukemia
Leukemia, 33, 9, pp. 2254-2265
Leukemia, 33(9), 2254-2265. Nature Publishing Group
Digital.CSIC. Repositorio Institucional del CSIC
instname
Leukemia, 33, 2254-2265
Leukemia, 33(9), 2254-2265. NATURE PUBLISHING GROUP
EuroClonality-NGS Working Group 2019, ' Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS ', Leukemia . https://doi.org/10.1038/s41375-019-0499-4
Leukemia, 33, 9, pp. 2254-2265
Leukemia, 33(9), 2254-2265. Nature Publishing Group
Digital.CSIC. Repositorio Institucional del CSIC
instname
Leukemia, 33, 2254-2265
Leukemia, 33(9), 2254-2265. NATURE PUBLISHING GROUP
EuroClonality-NGS Working Group 2019, ' Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS ', Leukemia . https://doi.org/10.1038/s41375-019-0499-4
Assessment of clonality, marker identification and measurement of minimal residual disease (MRD) of immunoglobulin (IG) and T cell receptor (TR) gene rearrangements in lymphoid neoplasms using next-generation sequencing (NGS) is currently under inten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de78cda79a5e6031838658ea5f867c70
https://hdl.handle.net/1887/121552
https://hdl.handle.net/1887/121552
Autor:
Clelia Tiziana Storlazzi, Zuzana Dostalova, Vojtech Bystry, Giovanni Cazzaniga, Manuel Quadri, Andrea Grioni, Daniela Silvestri, Grazia Fazio, Nikos Darzentas, Andrea Biondi, Claudia Saitta, Simona Songia, Silvia Rigamonti, Giulia Daniele
Publikováno v:
HemaSphere, Vol 3, Iss 3 (2019)
HemaSphere
HemaSphere
Supplemental Digital Content is available in the text
Acute lymphoblastic leukemia (ALL) is the most frequent pediatric cancer. Fusion genes are hallmarks of ALL, and they are used as biomarkers for risk stratification as well as targets for pre
Acute lymphoblastic leukemia (ALL) is the most frequent pediatric cancer. Fusion genes are hallmarks of ALL, and they are used as biomarkers for risk stratification as well as targets for pre